植物由来ワクチンの世界市場レポート 2025年

植物由来ワクチンの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.1％で27億9,000万米ドルに成長します。予測期間の成長は、パンデミックへの備え、世界の健康安全保障、ワクチン用途の拡大、製薬業界の採用に起因しています。予測期間の主な動向には、植物バイオテクノロジーの技術的進歩、環境の持続可能性、人工知能の統合、MLの統合などがあります。

感染症の高い蔓延が、今後の植物由来ワクチン市場の成長を牽引すると予想されます。感染症は、細菌、ウイルス、真菌、寄生虫などの細菌によって引き起こされる病気です。植物由来ワクチンは、感染症を含む様々な症状に対して伝統医学と現代医学の両方で使用されており、予防薬、ワクチン、治療薬として安全で効果的、安定的かつ手頃な価格の選択肢を提供することができます。例えば、2022年10月、スイスに本部を置く世界保健機関（WHO）の「世界結核報告」によると、世界の結核罹患者数は1,060万人、人口10万人当たりの罹患率は134人と推定されています。結核患者は東南アジア地域で多く報告されており、全体の45％を占め、アフリカが23％となっています。従って、感染症の有病率の高さが植物由来ワクチン市場の成長に拍車をかけています。

個別化医療に対する需要の高まりも、今後の植物由来ワクチン市場の成長に寄与すると予想されます。個別化医療は、個人特有の遺伝子構成に合わせた治療を行い、より効果的で正確なヘルスケアソリューションを提供します。植物由来ワクチンは、個人の遺伝子プロファイルに基づいて治療をカスタマイズできるようにすることで、個別化医療の一翼を担っており、ワクチン成分を特定の患者のニーズや反応に適合させることで、より安全で効果的な免疫療法を提供できる可能性があります。例えば、米国の専門家会員組織である個別化医療連合（Personalized Medicine Coalition）によると、2022年に食品医薬品局（Food and Drug Administration）の医薬品評価研究センター（CDER）は37の新規分子実体（NME）を承認し、35の治療用NMEのうち約34％（12）がPMCによって個別化医薬品に分類されました。したがって、個別化医療に対する需要の高まりが、植物由来ワクチン市場の拡大を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の植物由来ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の植物由来ワクチン市場：成長率分析
• 世界の植物由来ワクチン市場の実績：規模と成長, 2019-2024
• 世界の植物由来ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界の植物由来ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の植物由来ワクチン市場のワクチンの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細菌ワクチン
• ウイルスワクチン
• 寄生虫ワクチン
• その他のワクチンの種類
• 世界の植物由来ワクチン市場：原料別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タバコ草
• トウモロコシ
• じゃがいも
• その他の原料
• 世界の植物由来ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インフルエンザ
• ジカウイルス
• エボラウイルス
• 家禽の病気
• その他の用途
• 世界の植物由来ワクチン市場、ワクチンタイプ別サブセグメンテーション：細菌ワクチン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換え細菌ワクチン
• 結合細菌ワクチン
• DNAベースの細菌ワクチン
• 世界の植物由来ワクチン市場、ワクチンタイプ別サブセグメンテーション：ウイルスワクチン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ウイルスワクチン
• 生弱毒化ウイルスワクチン
• サブユニットウイルスワクチン
• 世界の植物由来ワクチン市場、ワクチンタイプ別サブセグメンテーション：寄生虫ワクチン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換え寄生虫ワクチン
• DNAベースの寄生虫ワクチン
• 世界の植物由来ワクチン市場、ワクチンタイプ別サブセグメンテーション：その他のワクチンタイプ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 真菌ワクチン
• 多価ワクチン
• 毒素ベースのワクチン

第7章 地域別・国別分析

• 世界の植物由来ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の植物由来ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 植物由来ワクチン市場：競合情勢
• 植物由来ワクチン市場：企業プロファイル
  • Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
  • British American Tobacco PLC Overview, Products and Services, Strategy and Financial Analysis
  • ICON Plc. Overview, Products and Services, Strategy and Financial Analysis
  • Agenus Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medicago Inc.
• Panacea Biotec Limited
• Creative Biolabs Inc.
• InVitria
• Fraunhofer USA Inc.
• Biodextris Inc.
• Intravacc B.V
• Avesthagen Limited
• Calyxt Inc.
• Zyus Life Sciences Inc.
• Mapp Biopharmaceutical Inc.
• Kentucky BioProcessing Inc.
• Planet Biotechnology Inc.
• Icon Genetics GmbH
• PlantForm Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 植物由来ワクチン市場2029：新たな機会を提供する国
• 植物由来ワクチン市場2029：新たな機会を提供するセグメント
• 植物由来ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Plant-based vaccines are recombinant vaccines that utilize antigens against specific infections incorporated into selected plants. These vaccines offer an effective means of treating various human and animal diseases.

The primary types of plant-based vaccines include bacterial vaccines, viral vaccines, parasite vaccines, and others. Bacterial vaccines involve preparations of either dead or weakened bacteria utilized as active immunizing agents. Various plant sources, including tobacco plants, maize, and potatoes, are employed for this purpose. Plant-based vaccines find applications in addressing diseases such as influenza, Zika virus, Ebola virus, poultry diseases, and others.

The plant-based vaccines market research report is one of a series of new reports from The Business Research Company that provides plant-based vaccines market statistics, including plant-based vaccines industry global market size, regional shares, competitors with a plant-based vaccines market share, detailed plant-based vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the plant-based vaccines industry. This plant-based vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based vaccines market size has grown rapidly in recent years. It will grow from $1.66 billion in 2024 to $1.83 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to traditional vaccine production challenges, need for cost-effective vaccine production, emergence of plant molecular farming, reduced allergenic potential, synthetic biology applications

The plant-based vaccines market size is expected to see rapid growth in the next few years. It will grow to $2.79 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to pandemic preparedness, global health security, expansion of vaccine applications, pharmaceutical industry adoption. Major trends in the forecast period include technological advancements in plant biotechnology, environmental sustainability, integration of artificial intelligence, and integration of ML.

The high prevalence of infectious diseases is expected to drive the growth of the plant-based vaccine market in the future. Infectious diseases are illnesses caused by germs, such as bacteria, viruses, fungi, or parasites. Plant-based vaccines, used in both traditional and modern medicine for various conditions, including infectious diseases, can offer safe, effective, stable, and affordable options for prophylactics, vaccines, and treatments. For instance, in October 2022, according to the Global Tuberculosis Report by the World Health Organization, a Switzerland-based global health agency, the global incidence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 population. TB cases were predominantly reported in the Southeast Asia region, accounting for 45% of the total, followed by Africa with 23%. Therefore, the high prevalence of infectious diseases is fueling the growth of the plant-based vaccine market.

The rising demand for personalized medicine is also expected to contribute to the growth of the plant-based vaccine market going forward. Personalized medicine tailors medical treatments to an individual's unique genetic makeup, providing more effective and precise healthcare solutions. Plant-based vaccines play a role in personalized medicine by allowing treatments to be customized based on individual genetic profiles, potentially offering safer and more effective immunotherapies by adapting vaccine components to specific patient needs and responses. For example, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and of the 35 therapeutic NMEs, around 34% (or 12) were classified as personalized medicines by the PMC. Therefore, the growing demand for personalized medicine is driving the expansion of the plant-based vaccine market.

Government funding for vaccine development is expected to further propel the growth of the plant-based vaccine market. Government funding refers to the investment that supports specific industries to advance various aspects. Numerous government agencies are financing vaccine development efforts, including for COVID-19 vaccines, which aids in the creation of different types of vaccines, including plant-based COVID-19 vaccines. For instance, in November 2022, the U.S. Department of Health and Human Services (HHS), a US-based government agency, launched a new $350 million initiative to support HRSA-backed health centers in boosting COVID-19 vaccination efforts. This funding enables health centers to develop COVID-19 vaccines through mobile, drive-up, walk-up, or community-based vaccination events and collaborate with community organizations and other efforts to increase vaccine administration.

Product innovation is a key trend gaining traction in the plant-based vaccine market. Leading companies in this sector are focused on developing innovative products to maintain their market position. For example, in February 2022, Medicago Inc., a Canada-based biopharmaceutical company, and GSK PLC, a UK-based pharmaceutical and biotechnology company, announced that Health Canada had approved COVIFENZ, a COVID-19 vaccine. COVIFENZ is the first plant-based virus-like particles (VLP), recombinant, adjuvanted vaccine available for COVID-19. It utilizes COVID-19-like particle (CoVLP) technology and consists of recombinant spike (S) glycoproteins produced as VLPs.

Major companies in the plant-based vaccine market are focusing on advanced solutions such as plant-technology platforms to optimize production scalability, improve vaccine efficacy, and streamline cost-effective manufacturing. Plant-technology platforms leverage plant systems to efficiently produce vaccines and therapeutic proteins. For instance, in January 2022, British American Tobacco, a UK-based consumer goods company, launched KBio Holdings Limited (KBio), a biotech company aimed at accelerating the research, development, and production of novel treatments. KBio is focused on treatments for rare and infectious diseases, harnessing both the plant-based technology platform and its existing clinical and pre-clinical vaccines and antibody pipeline. The plant-based production system offers potential benefits such as greater speed, scalability, and thermostability.

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plant-based vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based vaccines market consists of sales of cholera vaccines and norovirus vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plant-based vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plant-based vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Vaccine Type: Bacterial Vaccines; Viral Vaccines; Parasite Vaccines; Other Vaccine Types
• 2) By Source: Tobacco Plant; Maize; Potato; Other Sources
• 3) By Application: Influenza; Zika Virus; Ebola Virus; Poultry Disease; Other Applications
• Subsegments:
• 1) By Bacterial Vaccines: Recombinant Bacterial Vaccines; Conjugate Bacterial Vaccines; DNA-Based Bacterial Vaccines
• 2) By Viral Vaccines: Inactivated Viral Vaccines; Live Attenuated Viral Vaccines; Subunit Viral Vaccines
• 3) By Parasite Vaccines: Recombinant Parasite Vaccines; DNA-Based Parasite Vaccines
• 4) By Other Vaccine Types: Fungal Vaccines; Multivalent Vaccines; Toxin-Based Vaccines
• Companies Mentioned: Sanofi Pasteur SA; GlaxoSmithKline plc.; British American Tobacco PLC; ICON Plc.; Agenus Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plant-Based Vaccines Market Characteristics

3. Plant-Based Vaccines Market Trends And Strategies

4. Plant-Based Vaccines Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Plant-Based Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plant-Based Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plant-Based Vaccines Market Growth Rate Analysis
• 5.4. Global Plant-Based Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plant-Based Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plant-Based Vaccines Total Addressable Market (TAM)

6. Plant-Based Vaccines Market Segmentation

• 6.1. Global Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Vaccines
• Viral Vaccines
• Parasite Vaccines
• Other Vaccine Types
• 6.2. Global Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tobacco Plant
• Maize
• Potato
• Other Sources
• 6.3. Global Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Influenza
• Zika Virus
• Ebola Virus
• Poultry Disease
• Other Applications
• 6.4. Global Plant-Based Vaccines Market, Sub-Segmentation Of Bacterial Vaccines, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Bacterial Vaccines
• Conjugate Bacterial Vaccines
• DNA-Based Bacterial Vaccines
• 6.5. Global Plant-Based Vaccines Market, Sub-Segmentation Of Viral Vaccines, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Viral Vaccines
• Live Attenuated Viral Vaccines
• Subunit Viral Vaccines
• 6.6. Global Plant-Based Vaccines Market, Sub-Segmentation Of Parasite Vaccines, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Parasite Vaccines
• DNA-Based Parasite Vaccines
• 6.7. Global Plant-Based Vaccines Market, Sub-Segmentation Of Other Vaccine Types, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fungal Vaccines
• Multivalent Vaccines
• Toxin-Based Vaccines

7. Plant-Based Vaccines Market Regional And Country Analysis

• 7.1. Global Plant-Based Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plant-Based Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plant-Based Vaccines Market

• 8.1. Asia-Pacific Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plant-Based Vaccines Market

• 9.1. China Plant-Based Vaccines Market Overview
• 9.2. China Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plant-Based Vaccines Market

• 10.1. India Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plant-Based Vaccines Market

• 11.1. Japan Plant-Based Vaccines Market Overview
• 11.2. Japan Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plant-Based Vaccines Market

• 12.1. Australia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plant-Based Vaccines Market

• 13.1. Indonesia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plant-Based Vaccines Market

• 14.1. South Korea Plant-Based Vaccines Market Overview
• 14.2. South Korea Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plant-Based Vaccines Market

• 15.1. Western Europe Plant-Based Vaccines Market Overview
• 15.2. Western Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plant-Based Vaccines Market

• 16.1. UK Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plant-Based Vaccines Market

• 17.1. Germany Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plant-Based Vaccines Market

• 18.1. France Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plant-Based Vaccines Market

• 19.1. Italy Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plant-Based Vaccines Market

• 20.1. Spain Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plant-Based Vaccines Market

• 21.1. Eastern Europe Plant-Based Vaccines Market Overview
• 21.2. Eastern Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plant-Based Vaccines Market

• 22.1. Russia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plant-Based Vaccines Market

• 23.1. North America Plant-Based Vaccines Market Overview
• 23.2. North America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plant-Based Vaccines Market

• 24.1. USA Plant-Based Vaccines Market Overview
• 24.2. USA Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plant-Based Vaccines Market

• 25.1. Canada Plant-Based Vaccines Market Overview
• 25.2. Canada Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plant-Based Vaccines Market

• 26.1. South America Plant-Based Vaccines Market Overview
• 26.2. South America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plant-Based Vaccines Market

• 27.1. Brazil Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plant-Based Vaccines Market

• 28.1. Middle East Plant-Based Vaccines Market Overview
• 28.2. Middle East Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plant-Based Vaccines Market

• 29.1. Africa Plant-Based Vaccines Market Overview
• 29.2. Africa Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plant-Based Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Plant-Based Vaccines Market Competitive Landscape
• 30.2. Plant-Based Vaccines Market Company Profiles
  • 30.2.1. Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. British American Tobacco PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. ICON Plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agenus Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Plant-Based Vaccines Market Other Major And Innovative Companies

• 31.1. Medicago Inc.
• 31.2. Panacea Biotec Limited
• 31.3. Creative Biolabs Inc.
• 31.4. InVitria
• 31.5. Fraunhofer USA Inc.
• 31.6. Biodextris Inc.
• 31.7. Intravacc B.V
• 31.8. Avesthagen Limited
• 31.9. Calyxt Inc.
• 31.10. Zyus Life Sciences Inc.
• 31.11. Mapp Biopharmaceutical Inc.
• 31.12. Kentucky BioProcessing Inc.
• 31.13. Planet Biotechnology Inc.
• 31.14. Icon Genetics GmbH
• 31.15. PlantForm Corporation

32. Global Plant-Based Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plant-Based Vaccines Market

34. Recent Developments In The Plant-Based Vaccines Market

35. Plant-Based Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Plant-Based Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plant-Based Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plant-Based Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer